Medindia

X

Alexander L. Kunz is recognized by Continental Who's Who

Thursday, November 10, 2016 General News J E 4
Advertisement

RAMONA, Calif., Nov. 9, 2016 /PRNewswire/ -- Alexander L. Kunz is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medical, Health and Wellness. Alexander is the CEO and Founder of OP2 Labs (Frog Performance).

Designed as an advanced, clinically proven proprietary protein product for near instant absorption at the cellular level, FrogFuel is free of GMO's, fat, sugar, gluten and cholesterol with proven 100% digestibility in under fifteen minutes.

A navy seal turned entrepreneur, Alexander founded OP2 Labs with his seal teammate, Jeff Byers. Wanting to challenge the performance supplement marketplace, the pair created OP2 Labs to offer a true clinically driven protein supplement.

On the development of Frog Performance, Alexander states: "I want to have the consumer be able to have access to medical-grade product." He started with a concept and wants to bring it from a medical label to performance label.

Moreover, Alexander is recognized as investor and an expert in strategic business design. With the combination of his business acumen and entrepreneurial success, Alexander has the passion and ability to flourish in any business to attain optimal results. 

Looking into the future, Alexander plans on continuing growth and development of OP2 Labs products.

For more information, please visit www.op2labs.com

Contact: Katherine Green, 516-825-5634, pr@continentalwhoswho.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alexander-l-kunz-is-recognized-by-continental-whos-who-300359870.html

SOURCE Continental Who's Who

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
NAPHS Statement on the 2016 National Election
S
Nektar Therapeutics Presents New Clinical Data fro...